Items Tagged ‘antiplatelet’
March 17, 2021
Data show clear benefit from genetic testing before prescribing antiplatelet therapy
By Susan Murphy 
By Terri Malloy Pharmacogenomics is a valuable tool for health care providers to help prescribe the right drug for the right patient to enhance efficacy and avoid side effects. New research, funded in part by the National Heart, Lung and Blood Institute (NHLBI), shows a clear advantage of genetic testing in helping health care providers […]
Tags: antiplatelet, antiplatelet medication, coronary heart disease, Genetic Testing, pharmacogenomics
February 6, 2014
Your Genotype and Your Heart Health
By Center for Individualized Medicine 
Each year in the United States, 600,000 to 800,000 heart stents are placed to restore blood flow through coronary arteries. Patients are then given medication to keep blood clots from forming near the surgical site. Such clots can be deadly, causing heart attack and stroke. But, which antiplatelet medication is best? The answer may lie in your genes. “The […]
Tags: antiplatelet, antiplatelet medication, clopidogrel, dna test, DNA Testing, gene sequencing, genome science, genomic medicine, genomics, heart, heart attack, Heart Health
November 14, 2013
Genomics Of Antiplatelet Heart Medication Study At Mayo Clinic
By AJ Montpetit 
Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States. The answer may lie in your genes, but professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration’s recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate). The […]
Tags: antiplatelet, Cardiovascular Disease, center for individualized medicine, Genetic Testing, genome, genomics, heart medication, individualized medicine, mayo clinic, Naveen Pereira, personalized care, Personalized Medication
August 20, 2013
Genomics May Settle Debate on Best Antiplatelet Medication After Stenting
By AJ Montpetit
600,000 angioplasties are performed every year in the United States, which has raised the question of which antiplatelet medication is best after a coronary stent. Looking to individual’s genome is where the Center for Individualized Medicine is studying, with their newly launched TAILOR-PCI study. This study examines the CYP2C19 genotype of a patient to determine […]
Tags: angioplasty, antiplatelet, antiplatelet medication, center for individualized medicine, individualized medicine, mayo clinic, personalized medicine, pharmacogenomics